Value & Access
The EU has an European regulator and national value assessment authorities (e.g. HTAs and payers) with different remits, evidence requirements and approaches to uncertainty. Health technologies are increasingly being evaluated to determine their value and access. In this track we will explore how to respond to the challenges of determining the value of innovative and novel health technologies, different views of stakeholders and data requirements, and achieving patient-centric health systems (i.e. life cycle approach). The track will also explore different ways of anticipating and managing uncertainties across the lifecycle of a health technology, particularly involving Regulatory and Access landscapes. We invite abstracts containing multifunctional/ multistakeholder perspectives (at a minimum Regulatory and Access perspectives).
Who is This Track Designed For?
Professionals involved in patient access, market access, regulatory intelligence, health technology assessment, outcomes research, health economics, pricing and reimbursement, and regulatory strategy, from the industry as well as from governmental or public organizations and academics.
The online program is now available. Explore the rich content we offer across 10 thought leadership tracks.
Director, European Public Policy – Strategic EU Advocacy Lead
MSD Europe Inc., Belgium
Senior Scientific Researcher, Department for Health Evidence
Radboud University Medical Centre, Netherlands
President, Swiss Healthcare Industry Club (cHIC),
INSEAD Alumni Association Switzerland & Vice President
INSEAD Healthcare Alumni Network, Switzerland
Hear From Our Speakers
DIA Europe 2023 Highlights
It will provide updates on key developments on the GCP Renovation (ICH E6, ICH E8), Clinical Trial Regulation, the Clinical Trial Information System, data submission, transparency, navigating ethical approval, study design in the digital age, innovative clinical trial designs (umbrella and platform trials, patient centricity), digital tools in development and other hot topics. It should be a must-attend for optimising development programmes and identifying cost savings through efficiency and innovation.